arrow
T

Terry Stevens-Ayers

Fred Hutch Cancer Center
H指数:30
被引数:4,188

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Assessing VirScan serosurvey epitope profiling variability between in-clinic venous blood draw and capillary blood self-sampling device

评估VirScan血清学调查中院静脉血采集与毛细血管血自采样装置的表位分析变异性

2026-06-020
PRE
Influence of B cell-lineage targeted CAR-T cell therapy on humoral immunity and vaccine-induced antibody response

B细胞系靶向car-t细胞治疗对体液免疫和疫苗诱导的抗体反应的影响

2026-04-070
OAAI
Cytomegalovirus DNAemia in Hospitalized Adults With SARS-CoV-2 Infection Requiring Supplemental Oxygen: Virologic and Clinical Characteristics and Association With Outcomes

人巨细胞病毒DNA血症在需补充氧气治疗的住院SARS-CoV-2感染成人中的病毒学和临床特征及其与预后的关联

2026-01-010
PRE
Multiplex serology reveals age-specific immunodynamics of respiratory pathogens in the wake of the COVID-19 pandemic

多重血清学揭示了后疫情时代呼吸道病原体的年龄特异性免疫动力学

2025-12-100
OAAI
Respiratory Virus Infections and Pulmonary Impairment After Allogeneic Hematopoietic Cell Transplantation

同种异基因造血细胞移植后的呼吸道病毒感染与肺功能损害

2025-10-010
PRE
ELISPOT as a predictor of clinically significant cytomegalovirus infection after hematopoietic cell transplantation in letermovir recipients

ELISPOT 作为接受莱特莫韦治疗的造血细胞移植患者中临床显著巨细胞病毒感染的预测指标

2025-05-060
PRE
The Effect of Gastrointestinal Graft-Versus-Host Disease and Diarrhea on the Pharmacokinetic Profile of Sotrovimab in Hematopoietic Stem Cell Transplant Recipients
2024-05-141
OA
Cytomegalovirus (CMV) Reactivation and CMV-Specific Cell-Mediated Immunity After Chimeric Antigen Receptor T-Cell Therapy

嵌合抗原受体T细胞治疗后巨细胞病毒 (CMV) 再激活和CMV特异性细胞介导的免疫

2023-11-1718
OAAI
Pathogen-Specific Humoral Immunity and Infections in B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy Recipients with Multiple Myeloma

B细胞成熟抗原导向的嵌合抗原受体T细胞治疗多发性骨髓瘤患者的病原体特异性体液免疫和感染

2022-06-0126
OAAI
Association of Inherited Chromosomally Integrated Human Herpesvirus 6 with Neurologic Symptoms and Management after Allogeneic Hematopoietic Cell Transplantation

遗传染色体整合的人类疱疹病毒6与异基因造血干细胞移植后神经系统症状和管理的关联

2021-09-016
OAAI
Antibodies against vaccine-preventable infections after CAR-T cell therapy for B cell malignancies

B细胞恶性肿瘤car-t细胞治疗后疫苗可预防感染的抗体

2021-04-2957
OA